C.R. Freeman

2.6k total citations · 1 hit paper
9 papers, 2.0k citations indexed

About

C.R. Freeman is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, C.R. Freeman has authored 9 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in C.R. Freeman's work include Breast Cancer Treatment Studies (2 papers), Advanced Radiotherapy Techniques (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). C.R. Freeman is often cited by papers focused on Breast Cancer Treatment Studies (2 papers), Advanced Radiotherapy Techniques (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). C.R. Freeman collaborates with scholars based in Norway, Canada and Malaysia. C.R. Freeman's co-authors include Sidney J. Cutler, John W. Berg, Maurice M. Black, Sverre Harvei, T Mørk, William Parker, Paul R. Fortin, Vivian Ho, L. Kun and Carey Levinton and has published in prestigious journals such as Cancer, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

C.R. Freeman

7 papers receiving 1.9k citations

Hit Papers

Occurrence and prognosis of extranodal lymphomas 1972 2026 1990 2008 1972 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.R. Freeman Norway 5 1.6k 870 508 482 355 9 2.0k
Giovanni Serio Italy 15 1.4k 0.9× 1.3k 1.5× 497 1.0× 451 0.9× 504 1.4× 41 2.4k
Andreas Zettl Germany 30 1.3k 0.8× 1.1k 1.3× 363 0.7× 646 1.3× 357 1.0× 72 2.7k
Agustín Avilés Mexico 24 1.2k 0.8× 1.0k 1.2× 187 0.4× 410 0.9× 245 0.7× 114 1.9k
B. Vaughan Hudson United Kingdom 24 1.5k 1.0× 830 1.0× 199 0.4× 377 0.8× 522 1.5× 36 1.9k
Hye Jin Kang South Korea 26 905 0.6× 822 0.9× 326 0.6× 256 0.5× 461 1.3× 120 1.8k
Yoshikazu Kagami Japan 27 728 0.5× 936 1.1× 754 1.5× 253 0.5× 820 2.3× 97 2.1k
John J. Brooks United States 27 725 0.5× 696 0.8× 397 0.8× 199 0.4× 897 2.5× 53 2.1k
Kay M. Ristow United States 31 1.8k 1.2× 1.7k 1.9× 299 0.6× 417 0.9× 338 1.0× 76 2.9k
Onsi W. Kamel United States 27 1.2k 0.7× 1.4k 1.6× 297 0.6× 231 0.5× 182 0.5× 46 2.5k
Annarita Conconi Italy 24 1.9k 1.2× 1.0k 1.2× 339 0.7× 550 1.1× 386 1.1× 71 2.3k

Countries citing papers authored by C.R. Freeman

Since Specialization
Citations

This map shows the geographic impact of C.R. Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.R. Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.R. Freeman more than expected).

Fields of papers citing papers by C.R. Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.R. Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.R. Freeman. The network helps show where C.R. Freeman may publish in the future.

Co-authorship network of co-authors of C.R. Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of C.R. Freeman. A scholar is included among the top collaborators of C.R. Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.R. Freeman. C.R. Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Vallières, Martin, C.R. Freeman, Sonia Skamene, & Issam El Naqa. (2012). FDG-PET Features and Outcomes in Patients With Soft-tissue Sarcomas of the Extremities. International Journal of Radiation Oncology*Biology*Physics. 84(3). S167–S168.
2.
Ferro, Vito, et al.. (2005). PI-88, a heparanase inhibitor showing promising evidence of patient benefit in phase II clinical trials.. Clinical Cancer Research. 11(24). 1 indexed citations
3.
Cury, Fabio, Luís Souhami, R. Rajan, et al.. (2005). 122 A phase-II Trial of intermittent androgen ablation in patients presenting biochemical failure after definitive radiotherapy for localized prostate cancer. Radiotherapy and Oncology. 76. S36–S37. 1 indexed citations
4.
Benk, V., et al.. (1999). 2055 Effect of delay in initiating radiotherapy for patients with early stage breast cancer: Results of a natural experiment. International Journal of Radiation Oncology*Biology*Physics. 45(3). 305–306. 8 indexed citations
5.
Parker, William, et al.. (1999). 2286 3D treatment planning for pediatric whole CNS irradiation using CT-simulation and intensity modulated radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 45(3). 427–427. 2 indexed citations
6.
Freeman, C.R., et al.. (1992). Final results of a study of escalating doses of hyper fractionated radiotherapy in pediatric brain stem tumors. International Journal of Radiation Oncology*Biology*Physics. 24. 238–238. 5 indexed citations
7.
Freeman, C.R., John W. Berg, & Sidney J. Cutler. (1972). Occurrence and prognosis of extranodal lymphomas. Cancer. 29(1). 252–260. 1766 indexed citations breakdown →
8.
Black, Maurice M., C.R. Freeman, T Mørk, Sverre Harvei, & Sidney J. Cutler. (1971). Prognostic significance of microscopic structure of gastric carcinomas and their regional lymph nodes. Cancer. 27(3). 703–711. 131 indexed citations
9.
Cutler, Sidney J., C.R. Freeman, Maurice M. Black, T Mørk, & Sverre Harvei. (1969). Further observations on prognostic factors in cancer of the female breast. Cancer. 24(4). 653–667. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026